Anticancer properties of new flavonoid lensoside Aβ in combination with temozolomide in an in vitro model of human glioma cells

Simple item page
dc.contributor.authorMaciejczyk, Aleksandra
dc.contributor.authorKapral-Piotrowska, Justyna
dc.contributor.authorSumorek-Wiadro, Joanna
dc.contributor.authorZając, Adrian
dc.contributor.authorGruszecki, Wiesław I.
dc.contributor.authorLemieszek, Marta
dc.contributor.authorWertel, Iwona
dc.contributor.authorPecio, Łukasz
dc.contributor.authorŻuchowski, Jerzy
dc.contributor.authorSkalicka-Woźniak, Krystyna
dc.contributor.authorPawlikowska-Pawlęga, Bożena
dc.contributor.authorHułas-Stasiak, Monika
dc.contributor.authorRzeski, Wojciech
dc.contributor.authorRola, Radosław
dc.contributor.authorDobrowolski, Piotr
dc.contributor.authorJakubowicz-Gil, Joanna
dc.date.accessioned2025-11-07T08:09:03Z
dc.date.available2025-11-07T08:09:03Z
dc.date.issued2025-10-28
dc.description.abstractMalignant gliomas like astrocytoma IDH mutant and glioblastoma IDH wild type, particularly anaplastic astrocytoma and glioblastoma multiforme, represent significant therapeutic challenges due to their aggressive behavior and resistance to treatment. This study investigates the effect of simultaneous effects of the new flavonoid lensoside Aβ in combination with temozolomide in human glioma cell lines (T98G, MOGGCCM, LN-18, LN229, and SW1783). Emphasis was placed on the modulation of the PI3K/AKT/mTOR and RAF/MEK/ERK pathways, which are integral to cancer progression. Migration inhibition was evaluated through in vitro wound assays and scanning electron microscopy, whereas apoptosis and cell death were quantified via flow cytometry and fluorescence microscopy. The results revealed that lensoside Aβ enhances temozolomide’s efficacy, particularly in LN229 cells, while highlighting differential drug responses in LN-18 cells. These findings underscore the potential of combining lensoside Aβ with standard chemotherapeutics to mitigate glioma invasiveness and resistance, thereby opening avenues for molecular-targeted therapy strategies.
dc.identifier.citationBrain Research, 2025, 1869, 150014
dc.identifier.doi10.1016/j.brainres.2025.150014
dc.identifier.issnISSN: 0006-8993. eISSN: 1872-6240
dc.identifier.urihttps://bc.iung.pl/handle/123456789/3836
dc.language.isoen
dc.publisherElsevier
dc.subjectGliomas
dc.subjectlensoside Aβ
dc.subjectTemozolomide
dc.subjectMigration
dc.subjectProgrammed cell death
dc.subjectSEM
dc.subjectFTIR
dc.titleAnticancer properties of new flavonoid lensoside Aβ in combination with temozolomide in an in vitro model of human glioma cells
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Link do artykułu Anticancer properties of new flavonoid.pdf
Size:
127 KB
Format:
Adobe Portable Document Format
Download
Collections
Artykuły